Makoto Higuchi (National Institutes for Quantum and Radiological Science and Technology, Japan)
Session information
Symposium
[S-04] Update on Diagnostic Biomarkers for the early diagnosis of Alzheimer's Disease
Wed. May 22, 2019 1:20 PM - 3:20 PM Room 1 (Osaka International Convention Center 5F Large Hall)
Chair:Takeshi Iwatsubo(Department of Neuropathology, School of Medicine, The University of Tokyo, Japan), Hisatomo Kowa(Kobe University Graduate School of Health Sciences, Japan)
In recent advance of Alzheimer research field, development of tau imaging and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.
Koichi Tanaka (Koichi Tanaka Mass Spectrometry Research Laboratory Shimadzu Corporation, Japan)
Gustavo A. Jimenez-Maggiora1, Rema Raman1, Michael S. Rafii1, Reisa A. Sperling2,3, Jeffrey L. Cummings4, Paul S. Aisen1 (1.Alzheimer's Therapeutics Research Institute, University of Southern California, USA, 2.Department of Neurology, Massachusetts General Hospital, Harvard Medical School, USA, 3.Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Harvard Medical School, USA, 4.Cleveland Clinic Lou Ruvo Center for Brain Health, USA)
Takeshi Iwatsubo (Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Japan)